Fast-acting virus targets melanoma in mice

Fast-acting virus targets melanoma in mice
The green color shows where the vesicular stomatitis virus has infected rust-colored melanoma tumor cells after injection of the virus into the blood stream. The surrounding non-cancerous tissue is free of virus.

(Medical Xpress)—Yale researchers eradicated most melanoma tumors by exposing them to a fast-acting virus, they report in the June 15 edition of the Journal of Virology.

Melanoma is the deadliest type of and can spread throughout the body and even into the brain.

"After injection into the blood stream of mice, the virus finds melanoma on its own, and is fast and aggressive with tumors," said Anthony N. van den Pol, professor of neurosurgery at Yale School of Medicine, investigator for the Yale Cancer Center and senior author of the study. "Because the virus replicates rapidly, it can kill the melanoma before the immune system responds and kills the virus."

In the process of eliminating the virus, the immune system may also begin to target and kill , he added.

The researchers used the —part of a family of viruses that include rabies and may generate flu-like symptoms in humans. The fast-acting virus ignored healthy melanocytes (the cells from which melanoma arises) but zeroed in on 19 melanoma tumors studied. In 70 percent of tumors tested, melanoma was eradicated completely, while the rest showed a more limited response to the virus.

If safety of the virus can be substantiated, the next target would be to begin trials in humans, van den Pol said.


Explore further

Virus kills melanoma in animal model, spares normal cells

More information: jvi.asm.org/content/87/2/1019.full
Journal information: Journal of Virology

Provided by Yale University
Citation: Fast-acting virus targets melanoma in mice (2013, June 17) retrieved 24 August 2019 from https://medicalxpress.com/news/2013-06-fast-acting-virus-melanoma-mice.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more